Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis
Marina S. Gelman, Ron R. Kopito
Marina S. Gelman, Ron R. Kopito
View: Text | PDF
Perspective

Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis

  • Text
  • PDF
Abstract

Perspective

Authors

Marina S. Gelman, Ron R. Kopito

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Following initial synthesis and membrane integration (step 1), nascent C...
Following initial synthesis and membrane integration (step 1), nascent CFTR molecules are inefficiently folded (step 2) and are recognized as misfolded by one or more components of the quality control machinery (red; step 3a), which may interact with cytoplasmic, membrane, or lumenal portions of CFTR. This interaction is necessary to dislocate CFTR to the cytoplasmic ubiquitin (green spheres) conjugation machinery (step 3b), which then directs it to the proteasome for degradation (step 3c). Cytoplasmic aggregates form (step 3d) when the rate of production and dislocation of misfolded CFTR exceeds the capacity of the ubiquitin-proteasome system for degradation.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts